|
1
|
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.
|
Pediatr Blood Cancer
|
2007
|
16.96
|
|
2
|
Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.
|
Blood
|
2002
|
3.54
|
|
3
|
Construction of long DNA molecules using long PCR-based fusion of several fragments simultaneously.
|
Nucleic Acids Res
|
2004
|
3.30
|
|
4
|
Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification.
|
Blood
|
2007
|
2.61
|
|
5
|
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
|
Blood
|
2013
|
2.46
|
|
6
|
Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol.
|
Blood
|
2011
|
2.35
|
|
7
|
Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis.
|
Br J Haematol
|
2005
|
1.64
|
|
8
|
Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis.
|
Br J Haematol
|
2007
|
1.27
|
|
9
|
2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
|
Pediatr Blood Cancer
|
2009
|
1.12
|
|
10
|
Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization.
|
J Biol Chem
|
2004
|
1.04
|
|
11
|
Membrane ganglioside enrichment lowers the threshold for vascular endothelial cell angiogenic signaling.
|
Cancer Res
|
2006
|
0.99
|
|
12
|
Ganglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts.
|
Glycobiology
|
2008
|
0.96
|
|
13
|
Alteration of ganglioside synthesis by GM3 synthase knockout in murine embryonic fibroblasts.
|
Biochim Biophys Acta
|
2007
|
0.92
|
|
14
|
Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry.
|
J Pediatr
|
2008
|
0.90
|
|
15
|
Biological stratification of human neuroblastoma by complex "B" pathway ganglioside expression.
|
Cancer Res
|
2003
|
0.88
|
|
16
|
Inhibition of TLR activation and up-regulation of IL-1R-associated kinase-M expression by exogenous gangliosides.
|
J Immunol
|
2008
|
0.87
|
|
17
|
Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase.
|
Cancer Res
|
2003
|
0.86
|
|
18
|
Modulation of growth factor signaling by gangliosides: positive or negative?
|
Methods Enzymol
|
2006
|
0.84
|
|
19
|
Mechanisms of ganglioside inhibition of APC function.
|
J Immunol
|
2003
|
0.83
|
|
20
|
Tumor gangliosides accelerate murine tumor angiogenesis.
|
Angiogenesis
|
2013
|
0.82
|
|
21
|
Ganglioside GD1a impedes lipopolysaccharide-induced maturation of human dendritic cells.
|
Cell Immunol
|
2002
|
0.82
|
|
22
|
Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.
|
Blood
|
2005
|
0.81
|
|
23
|
Transfection of glucosylceramide synthase antisense inhibits mouse melanoma formation.
|
Glycobiology
|
2002
|
0.81
|
|
24
|
N-butyldeoxynojirimycin inhibits murine melanoma cell ganglioside metabolism and delays tumor onset.
|
Cancer Lett
|
2003
|
0.81
|
|
25
|
Modulation of CD4 Th cell differentiation by ganglioside GD1a in vitro.
|
J Immunol
|
2005
|
0.81
|
|
26
|
Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood.
|
Br J Haematol
|
2014
|
0.81
|
|
27
|
Low complex ganglioside expression characterizes human neuroblastoma cell lines.
|
Cancer Lett
|
2005
|
0.80
|
|
28
|
Ganglioside inhibition of CD8+ T cell cytotoxicity: interference with lytic granule trafficking and exocytosis.
|
J Immunol
|
2012
|
0.79
|
|
29
|
Induction of GM1a/GD1b synthase triggers complex ganglioside expression and alters neuroblastoma cell behavior; a new tumor cell model of ganglioside function.
|
Glycoconj J
|
2011
|
0.78
|
|
30
|
Ganglioside-exposed dendritic cells inhibit T-cell effector function by promoting regulatory cell activity.
|
Immunology
|
2010
|
0.77
|
|
31
|
Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC.
|
Cancer Biol Ther
|
2006
|
0.76
|
|
32
|
Immunosuppressive treatment for chemotherapy-resistant multisystem Langerhans cell histiocytosis.
|
Med Pediatr Oncol
|
2003
|
0.75
|